TherapeuticsMD, Inc. (TXMD) NASDAQ

1.21

-0.04(-3.20%)

Updated at October 29 04:00PM

Currency In USD

Valuation

Market Cap9.92M
Enterprise Value12.03M
P/E Ratio-30.51
PEG Ratio-0.39
Price/Sales Ratio5.47
Price/Book Ratio0.51
Enterprise/Revenue5.34
Enterprise/EBITDA-9.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.18
Operating Margin-1.07

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue1.76M
Revenue/Share0.22
Gross Profit1.76M
EBITDA-2.98M
Net Income-2.18M
Diluted EPS-0.19

Balance Sheet

Total Cash6.07M
Total Cash/Share0.52
Total Debt5.72M
Total Debt/Equity0.21
Current Ratio2.89
Book Value Per Share2.36

Price History

52-Week Change-21.94
52-Week High2.44
52-Week Low0.7
Moving Average 50 Days1.11
Moving Average 200 Days1.11

Statistics

Average Volume170,389
Shares Outstanding11.57M
% Held by Institutions28.13

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 09, 2022